Wilcure Remedies Profile
Key Indicators
- Authorised Capital ₹ 4.00 M
as on 24-10-2024
- Paid Up Capital ₹ 3.59 M
as on 24-10-2024
- Company Age 20 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 6.70 Cr
as on 24-10-2024
- Satisfied Charges ₹ 4.93 Cr
as on 24-10-2024
- Revenue -12.72%
(FY 2023)
- Profit -26.24%
(FY 2023)
- Ebitda 6.21%
(FY 2023)
- Net Worth 18.41%
(FY 2023)
- Total Assets 4.08%
(FY 2023)
About Wilcure Remedies
The Corporate was formerly known as Vostok And Wilcure Remedies Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 4.00 M and a paid-up capital of Rs 3.59 M.
The company currently has active open charges totaling ₹6.70 Cr. The company has closed loans amounting to ₹4.93 Cr, as per Ministry of Corporate Affairs (MCA) records.
Jay Saraf, Devendra Saraf, and Shailendra Saraf serve as directors at the Company.
- CIN/LLPIN
U24232MP2004PTC017022
- Company No.
017022
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Oct 2004
- Date of AGM
28 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Gwalior
Industry
Company Details
- LocationIndore, Madhya Pradesh
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Wilcure Remedies Private Limited offer?
Wilcure Remedies Private Limited offers a wide range of products and services, including Antacid Drugs, Omeprazole Capsule, Mineral Supplement, Calcium Tablet, Common Disease Medicines, Pharmaceutical Tablets, Nutraceuticals & Dietary Supplements, Antihistamines, Anti Infective Drugs & Medicines, Antibiotic Tablets, Capsule & Syrup.
Who are the key members and board of directors at Wilcure Remedies?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jay Saraf  | Director | 08-Oct-2004 | Current |
| Devendra Saraf | Director | 08-Oct-2004 | Current |
| Shailendra Saraf | Director | 08-Oct-2004 | Current |
Financial Performance of Wilcure Remedies.
Wilcure Remedies Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 12.72% decrease. The company also saw a substantial fall in profitability, with a 26.24% decrease in profit. The company's net worth Soared by an impressive increase of 18.41%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Wilcure Remedies?
In 2023, Wilcure Remedies had a promoter holding of 0.28% and a public holding of 99.72%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 08 Apr 2024 | ₹1.55 M | Open |
Others Creation Date: 05 Aug 2022 | ₹4.50 Cr | Open |
Others Creation Date: 04 Aug 2022 | ₹1.00 Cr | Open |
How Many Employees Work at Wilcure Remedies?
Wilcure Remedies has a workforce of 7 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Wilcure Remedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Wilcure Remedies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
